Small Stocks, Big Money™

Gorilla Technology (Nasdaq: GRRR) completed the purchase of 1.1 million shares as part of its accelerated buyback program, capitalizing on what it sees as substantial undervaluation of its stock. Backed by over $40 million in unrestricted cash, the company plans to continue share repurchases, reinforcing confidence in its long-term growth. CEO Jay Chandan highlighted Gorilla's focus on aggressive business expansion, financial strength, and shareholder value. Recent contract wins in Taiwan and Colombia further showcase the company's execution on its growth strategy in AI-powered cybersecurity and data intelligence.

Alliance Entertainment (Nasdaq: AENT) reported a significant financial rebound for fiscal year 2024, with net income reaching $4.6 million—a $40 million improvement from the prior year’s loss. Operational efficiencies and a focus on margin enhancement drove a 24% increase in gross profit, raising gross margins to 11.7%. As the company looks toward fiscal 2025, it plans to fuel growth through expansion, new exclusive licenses, and stronger retail partnerships. Investments in technologies like Sure Sort® X and AutoStore™ are already streamlining operations, with further efficiency gains expected to boost profitability in the coming quarters.

GreenPower Motor Company (Nasdaq: GP) has received orders for six all-electric, zero-emission school buses from Arizona’s RWC Group, funded by the EPA's Clean School Bus Program. These buses, a mix of GreenPower’s Type D BEAST and Type A Nano BEAST models, will serve three Arizona school districts. GreenPower’s buses, praised for their safety, sustainability, and performance, represent the growing adoption of zero-emission transportation in schools. With $5 billion in federal funding available, additional orders are anticipated as the demand for eco-friendly school transportation increases.

Nutriband (Nasdaq: NTRB) authorized a $1 million share repurchase program, demonstrating confidence in its long-term value. As of September 16, 2024, the company had 11.1 million shares outstanding. Meanwhile, Nutriband continues to progress on its flagship AVERSA Fentanyl patch, with plans to submit a New Drug Application (NDA) to the FDA in early 2025. The AVERSA™ technology aims to deter abuse and misuse of transdermal pharmaceutical products, positioning Nutriband at the forefront of innovation in abuse-deterrent drug delivery systems.